Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Three-Dimensional Electroanatomical Mapping Versus Conventional Fluoroscopy-Guided Slow Pathway Ablation for Typical Atrioventricular Nodal Re-Entrant Tachycardia: A Prospective Randomized Study

NCT07630480 is registered in ClinicalTrials.gov with Kafrelsheikh University as lead sponsor.

NCT NCT07630480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07630480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Three-Dimensional Electroanatomical Mapping Versus Conventional Fluoroscopy-Guided Slow Pathway Ablation for Typical Atrioventricular Nodal Re-Entrant Tachycardia: A Prospective Randomized Study
Lead sponsor
Kafrelsheikh University
Phase
Not applicable
Overall status
Completed
Start date
December 30, 2023
Completion date
November 23, 2025
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrioventricular nodal reentry tachycardia, supraventricular tachycardia (svt)